Corcept Therapeutics
(CORT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,635 | 45,909 | 52,230 | 59,201 | 24,578 |
| TOTAL | $39,775 | $46,336 | $52,685 | $59,805 | $24,996 |
| Non-Current Assets | |||||
| PPE Net | 26 | 3 | 3 | 4 | 4 |
| Other Non-Current Assets | 32 | 40 | 32 | 28 | 104 |
| TOTAL | $58 | $43 | $35 | $32 | $108 |
| Total Assets | $39,833 | $46,379 | $52,720 | $59,837 | $25,104 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,611 | 1,066 | 2,291 | 1,865 | 817 |
| Accrued Expenses | 882 | 987 | 1,013 | 921 | 2,621 |
| Other current liabilities | N/A | N/A | N/A | N/A | 422 |
| TOTAL | $5,026 | $2,713 | $3,856 | $3,196 | $3,860 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,026 | $2,713 | $3,856 | $3,196 | $3,860 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 84,354 | 84,231 | 84,203 | 83,972 | 83,969 |
| Common Shares | 84 | 84 | 84 | 84 | 72 |
| Retained earnings | -208,558 | -198,622 | -192,187 | -183,305 | -176,204 |
| Other shareholders' equity | 0 | -5 | -6 | -59 | -97 |
| TOTAL | $34,807 | $43,666 | $48,864 | $56,641 | $21,244 |
| Total Liabilities And Equity | $39,833 | $46,379 | $52,720 | $59,837 | $25,104 |